Compare YFOR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YFOR | ADIL |
|---|---|---|
| Founded | N/A | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 18.5M |
| IPO Year | 2023 | 2017 |
| Metric | YFOR | ADIL |
|---|---|---|
| Price | $1.44 | $4.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | ★ 312.4K | 43.0K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $0.13 |
| 52 Week High | $2.05 | $7.20 |
| Indicator | YFOR | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 55.52 | 38.86 |
| Support Level | $1.22 | $3.84 |
| Resistance Level | $1.82 | $5.08 |
| Average True Range (ATR) | 0.18 | 0.49 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 37.42 | 11.43 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.